Dignify Therapeutics
Research Triangle Park, US · Founded 2013 · Delaware LLC · 2 known investors
Dignify Therapeutics develops "on demand" drugs that trigger emptying of the bladder and/or bowel when a person chooses, aimed at restoring control of bowel and bladder function. It operates in the biotechnology and pharmaceutical space focused on therapeutics for people with impaired bladder and bowel control.
Founders & leadership
KB
Karl B ThorExecutive Officer, Director, Promoter
EC
Edward C BurgardExecutive Officer, Director, Promoter
BW
Benny WardExecutive Officer, Director, Promoter
DJ
Daniel J RiccaDirector, Promoter
EV
Ebrahim VersiDirector, Promoter
KT
Karl Thor
FE
Fred EshelmanDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$3.4MraisedFeb 2015 · 7 investors · PharmaceuticalsRule 506(c)
▶$3.4MraisedFeb 2015 · 7 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Mary KatofiascPromoter
- Tatyana TouzovaPromoter
- Karl B ThorExecutive Officer, Director, Promoter
- Edward C BurgardExecutive Officer, Director, Promoter
- Benny WardExecutive Officer, Director, Promoter
- Daniel J RiccaDirector, Promoter
- Ebrahim VersiDirector, Promoter
- Florenta Aura KullmannPromoter
- Fred EshelmanDirector
- Venkateswarlu KarichetiPromoter
- Lesley MarsonPromoter
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- Minimum investment
- $100K
- Proceeds to insiders
- $1M
- First sale
- Oct 2014
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.